News Archives - QualityStocks

TuesdayMar 24, 2026 11:15 am

Heartbeam Inc. (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation

The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate AI-based ECG Algorithms The collaboration is focused on building next-generation, personalized AI-ECG algorithms for wellness and clinical applications, including assessing heart attack risk HeartBeam’s role in this evolving landscape is anchored by its HeartBeam System HeartBeam (NASDAQ: BEAT) recently announced a collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology, marking another step in the company’s push to expand its role in next-generation cardiac monitoring. The announcement highlights HeartBeam’s growing focus on artificial intelligence (“AI”)-enabled analysis and reinforces the relevance of its technology…

TuesdayMar 24, 2026 10:30 am

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Sees Important Geological Indicators for Advancing Clayton Silver Project Exploration

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX Gold & Silver Corp., an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, sees compelling prospects for unexplored areas of the project, magnified by the growing value of silver According to J.P. Morgan Global Research, silver prices are projected to average $81/oz in 2026, double their average in 2025, encouraging aggressive exploration of the historically productive but largely unexplored site In January 2026, the company commenced a non-brokered private placement financing for aggregate gross proceeds of up to CAN$2,000,000…

TuesdayMar 24, 2026 9:45 am

Landmark Proton Therapy Data Changes the Conversation; LIXTE Saw It Coming

A landmark Phase III trial published in The Lancet demonstrated a five-year overall survival rate of 90.9% for oropharyngeal cancer patients treated with proton therapy, compared with 81% for those receiving traditional radiation Proton therapy's ability to stop at a precise depth within the body reduces radiation exposure to surrounding healthy tissue, a clinical advantage driving new facility investments across the U.S., including a proton center scheduled to open this summer in Boca Raton, Florida LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) implemented some cohesion beyond pharmaceuticals in November 2025 with the acquisition of Liora Technologies Europe Ltd., now a subsidiary…

TuesdayMar 24, 2026 9:00 am

Soligenix Inc. (NASDAQ: SNGX) Spotlighted in Recent Zacks Research Report as Key Clinical Milestones Approach

Soligenix is entering a pivotal period marked by several anticipated clinical readouts and milestones expected throughout 2026. At the heart of the Zacks analysis is HyBryte(TM), which Soligenix is evaluating in the Phase 3 FLASH2 study for the treatment of CTCL. Beyond HyBryte, the report also points to progress involving SGX945, or dusquetide, for Behçet’s disease. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing therapies for rare diseases and unmet medical needs, is featured in a detailed research report issued by Zacks Small-Cap Research. The March 12 report provides a comprehensive look at the company’s pipeline, financial positioning…

MondayMar 23, 2026 12:00 pm

Service Robotics Enters Its Commercial Era as Real Deployment Takes Center Stage

The global service robotics market is projected to exceed $107 billion by 2030 as commercialization replaces experimentation TechForce Robotics delivers both TIM-E mobility robots and BIM-E beverage automation through a fully managed Robotics-as-a-Service Provider subscription model Modular transport systems and automated beverage platforms are designed for high-traffic, real-world hospitality and institutional environments Autonomous-driven robotics is shifting from concept demonstrations to measurable operational deployment. As labor shortages and wage pressures persist across hospitality, healthcare and public venues, automation is increasingly viewed as infrastructure rather than innovation theater. Nightfood Holdings Inc. (d.b.a. TechForce Robotics) (OTCQB: NGTF), is aligning with that transition by…

MondayMar 23, 2026 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Strengthens Its Financial Leadership and Corporate Infrastructure with Appointment of Jason Tong as Chief Financial Officer

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties, just announced the appointment of Jason Tong as its new CFO Mr. Tong will lend his experience spanning more than 15 years, equipping ESGold with the support needed for its next phase of growth Tong will be key in driving the company’s financial strategy as it transitions toward becoming a producing gold and silver company ESGold (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing…

MondayMar 23, 2026 10:30 am

Safe Pro Group Inc. (NASDAQ: SPAI) Successfully Uses the Company’s AI Tools in Real-World Operational Environments at Recent U.S. Army Event

Safe Pro recently announced that it has completed the company’s participation in a recent U.S. Army event where soldiers used Safe Pro’s AI tools in real-world operational environments. Safe Pro’s patented Safe Pro Object Threat Detection (“SPOTD") drone imagery analysis platform was used by soldiers to identify ground-based threats during day and night exercises. The threat data collected was also used by the company’s edge-based Navigation, Observation & Detection Engine (“NODE”) to create 2D/3D terrain maps and digital surface models to inform route and mission planning. Safe Pro Group (NASDAQ: SPAI), a developer of AI-powered defense, security, and situational awareness…

MondayMar 23, 2026 9:45 am

Beeline Holdings Inc. (NASDAQ: BLNE) Launches Self-Service Mortgage Platform to Offer Greater Flexibility and Control to Borrowers

The company has introduced a Self-Service Mortgage Experience (“SSME”) allowing borrowers to review loan customized scenarios and lock rates online without speaking to a loan officer. The feature provides a 24/7 digital mortgage pathway, reflecting growing demand for self-directed financial services among Millennials and Gen Z. Beeline’s AI-powered platform processes applications in seconds and presents personalized mortgage rate options rather than static rate quotes. The company’s broader digital infrastructure enables loan closings in 14–21 days, significantly faster than the traditional mortgage timeline. The platform targets two major demographic opportunities: younger homebuyers an investors seeking entry into property markets, plus older…

MondayMar 23, 2026 9:00 am

Growth Companies and Capital Markets Take Center Stage at the 38th Annual ROTH Conference

The relationship between growth companies and the capital markets has rarely been static. Periods of economic expansion often reward bold innovation and aggressive scaling, while more disciplined market environments place greater emphasis on operational execution, capital efficiency, and strategic clarity. As markets continue to recalibrate following several years of volatility and shifting interest-rate expectations, the dialogue between investors and emerging growth companies has become increasingly focused on fundamentals. That evolving conversation will be front and center at the 38th Annual ROTH Conference, taking place March 22–24, 2026, in Dana Point, California. The event is expected to bring together approximately 500…

FridayMar 20, 2026 11:15 am

Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs. The UK Medicines and Healthcare Products Regulatory Agency granted Promising Innovative Medicine designation to Soligenix’s SGX945 (dusquetide) for the treatment of Behçet’s disease. The recent designation in the United Kingdom builds on other regulatory recognitions previously granted to dusquetide. Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and…

Site Search

Company Search

Category: News